Axelpharm demands a license for anti-cancer drug from AstraZeneca
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
The Supreme Court of the Russian Federation (SC) allowed the authorities to recover losses incurred due to the failure to...